Facebook

Unleashing the Power of Zinc: A Pioneering Breakthrough in the Fight Against CancerStep into the world of Dr. Frederic E. Mohs, the visionary behind a game-changing approach to combat skin cancer. In a groundbreaking experiment in 1933, a young and determined Mohs injected various chemicals into rat tissues, unveiling the astonishing potential of topical zinc compositions as a potent anti-cancer agent.Fast forward to today, where Mohs' surgical technique aims to obliterate tumors while safeguarding precious healthy tissue. But amidst all the advancements, it seems that the remarkable role of zinc has been overlooked.Join us as we delve into the forgotten hero - zinc - and explore its pivotal role in the battle against cancer. Prepare to be amazed by the untapped potential of this humble element.Zinc is required in all body tissues and fluids. Zinc deficiency can lead to a number of different health problems. ... See MoreSee Less
Discover the Signs of Kidney Cancer - Unveiling the Facts about this Silent DiseaseUnveiling the Truth about Kidney Cancer - Don't Miss the Warning Signs!Did you know that kidney cancer, also known as renal cancer, can quietly wreak havoc in your body? This stealthy disease starts in the bean-shaped organ responsible for filtering blood and eliminating waste.But here's the thing – kidney cancer can be either benign or malignant. The good news? Most cases are detected early, before they have a chance to spread. However, if left undiscovered and untreated, this sneaky disease can wreak havoc on your body.Educate yourself about the silent symptoms of kidney cancer, so you can catch it before it catches you. ... See MoreSee Less

Twitter

Twitter feed is not available at the moment.

Discover What is RNA - Rna Based Drug Discovery

March 9, 2022
Est. Reading: 3 minutes

RNA Based Drug Discovery

Conventional drug therapies have limitations. They can be expensive, and they may have undesirable side effects. In some cases, they are not effective against certain types of cancer. Rna-based drug therapies may offer a more promising approach to treating cancer and other diseases. What is RNA?

What is RNA?

RNA is a molecule that plays a role in the genetic information process. It is made up of building blocks called nucleotides. There are four different types of nucleotides in RNA: adenine, cytosine, guanine, and uracil. Each nucleotide is made up of a nitrogenous base, a five-carbon sugar, and a phosphate group.

rna based drug discovery

To breakthrough, the medical industry is devoting time and money to cellular biology and developing treatments that effectively shut down genes tied to life-threatening diseases and genetic disorders like MRSA.

RNA has several important roles in the body. It helps to translate the genetic information in DNA into proteins. It also helps to regulate gene expression. Rna-based drugs can interfere with these essential functions, which may offer a new way to treat diseases like cancer.

There are numerous types of RNA-based drugs. Some work by blocking the translation of DNA into proteins. Others work by interfering with the expression of genes. Some RNA-based drugs are designed to target cancer cells specifically.

RNA-based drugs offer a number of advantages over traditional drug therapies. They are more specific than traditional drugs, which means they have fewer side effects. They are also easier to produce, and they are less expensive to manufacture.

RNA-based drugs are still in the early stages of development, and more research is needed to determine their effectiveness. However, they offer a promising new approach to treating disease.

 

Why are companies investing in mRNA drugs?

The potential for RNA drugs to revolutionize disease treatment is huge. The market for these drugs is expected to reach $32 billion by 2025. Many large pharmaceutical companies are investing in mRNA drug development, including Roche, Novartis, AstraZeneca, and Merck.

RNA-based drugs offer a new way to treat diseases like cancer, and they are easier and less expensive to produce than traditional drugs. They are still in the early stages of development, but they offer a promising new approach to disease treatment. Pharmaceutical companies are investing in RNA-based drugs because of their potential to revolutionize disease treatment.

approved rna drugs

RNA vs DNA

RNA and DNA are both important molecules that play a role in the genetic information process. They are made up of different building blocks, called nucleotides. RNA has four different types of nucleotides: adenine, cytosine, guanine, and uracil. DNA has five different types of nucleotides: adenine, cytosine, guanine, thymine, and uracil.

RNA is responsible for translating the genetic information in DNA into proteins. It also helps to regulate gene expression. DNA is responsible for carrying the genetic information in chromosomes.

 

Approved RNA Drugs

There are currently three RNA drugs that have been approved by the FDA:

1. Alnylam's Onpattro (patisiran) is a drug for the treatment of hereditary transthyretin-mediated amyloidosis, a rare genetic disorder.

2. Ionis' Spinraza (nusinersen) is a drug for the treatment of spinal muscular atrophy, a rare genetic disorder.

3. Roche's Luxturna (voretigene neparvovec) is a gene therapy drug for the treatment of Leber congenital amaurosis, a rare inherited form of blindness.

rna vs dna

There are several other RNA drugs that are currently in clinical trials:

1. Novartis' Zilretta (riluzole) is a drug for the treatment of osteoarthritis.

2. Sanofi's Dupixent (dupilumab) is a drug for the treatment of atopic dermatitis.

3. AstraZeneca's Imfinzi (durvalumab) is a drug for the treatment of lung cancer.

4. Merck's Keytruda (pembrolizumab) is a drug for the treatment of various types of cancer.

5. Genentech's Actemra (tocilizumab) is a drug for the treatment of rheumatoid arthritis.

In conclusion, RNA-based drugs are a promising new approach to treating disease. They are more specific than traditional drugs, easier to produce, and less expensive to manufacture. Pharmaceutical companies are investing in RNA-based drugs because of their potential to revolutionize disease treatment. RNA-based drugs offer a new way to treat diseases like cancer, and they are easier and less expensive to produce than traditional drugs.

We hope you liked this article. Please share it with your friends. Thank you for reading!

 

Sharing is caring
Copyright © 2023 All Rights Reserved
cross linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram